Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 USD | -0.29% | -5.65% | -7.75% |
30/05 | Transcript : Roivant Sciences Ltd., Q4 2024 Earnings Call, May 30, 2024 | |
30/05 | Roivant Sciences' Fiscal Q4 Net Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.75% | 765.32Cr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Insider Sold Shares Worth $79,650,463, According to a Recent SEC Filing